期刊文献+

乳腺癌组织中PTEN的表达及其临床意义 被引量:7

Expression and significance of tumor suppressor gene PTEN in breast carcinoma
下载PDF
导出
摘要 目的研究肿瘤抑制基因PTEN在乳腺癌组织中的表达及临床意义。方法采用免疫组化染色检测146例乳腺癌组织和10例乳腺癌癌旁正常组织PTEN蛋白的表达情况。结果10例乳腺癌癌旁正常组织均有PTEN表达,免疫组化染色较强PTEN表达于乳腺小叶腺泡上皮细胞及导管上皮细胞的胞质和胞核。146例乳腺癌组织的PTEN阳性表达率为57·5%(84/146)PTEN蛋白表达于癌细胞的胞质和胞核,PTEN表达与乳腺癌原发肿瘤的大小、病理分期以及雌激素受体(ER)、孕激素受体(PR)有关,PTEN高表达的乳腺癌患者2年生存情况明显优于低表达者(P<0·05),且ER、PTEN同时表达的乳腺癌患者2年无病生存率高于其中之一未表达或均未表达者(P<0·05)。结论乳腺癌组织中存在肿瘤抑制基因PTEN的表达缺失或减弱,可能与乳腺癌的发生、发展及预后有关。 Objective To investigate the expression of tumor suppressor gene PTEN in breast carcinomas and its significance. Methods Immunohistochemical method was used to detect the expression of PTEN gene in 146 cases of breast carcinoma and 10 specimens of norreal breast tissue closely adjacent to carcinoma. Results It was showed that PTEN gene was expressed in all 10 specimens of breast tissue closely adjacent to carcinoma. Expression of PTEN was localized in cytoplasm and nuclei of epithelial cells of lobular acini and epithelial cells of ducts. The rate of PTEN expression was 57.5% (84/146) in breast carcinoma. Expression of PTEN was related to tumor size, pathological stage, and the expression of ER and PR of breast cancer. The 2-year disease free survival of PTEN high expression breast cancer patients was superior to those with low expression (P〈0.05), and the 2-year disease free survival of both ER and PTEN positive breast cancer patients was higher than those with only ER or PTEN positive or both of them negative breast cancer (P〈0.05). Conclusion This study suggested that tumor suppressor gene PTEN was abnormally expressed in breast carcinoma. PTEN probably plays an important role in the tumorigenesis and development and prognosis of breast cancer.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2006年第10期963-965,共3页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金资助项目(30000201 30471946) 北京市自然科学基金资助项目(7052056)
关键词 基因 PTEN 乳腺肿瘤 免疫组织化学 病理学 临床 genes, PTEN breast neoplasms immunohistochemistry pathology, clinical
  • 相关文献

参考文献7

  • 1Gimm O,Perren A,Weng LP et al.Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue,and benign and malignant epithelial thyroid tumors.Am J Pathol,2000,156(5):1693
  • 2Perren A,Weng LP,Boag AH et al.Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.Am J Pathol,1999,155(4):1253
  • 3Depowski PL,Rosenthal SI,Ross JS.Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer.Mod Pathol,2001,14(7):672
  • 4林勤,庄严阵,许东坡,叶建新,陈佩琼.乳腺癌中PTEN蛋白表达及其与p27^(kip1)和cyclin D1表达的相关性[J].中华肿瘤杂志,2003,25(3):246-249. 被引量:27
  • 5Lee JS,Kim HS,Kim YB et al.Reduced PTEN expression is associated with poor outcome and angiogenesis in invasive ductal carcinoma of the breast.Appl Immunohistochem Mol Morphol,2004,12(3):205
  • 6Shoman N,Klassen S,McFadden A et al.Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen.Mod Pathol,2005,18(2):250
  • 7Shi W,Zhang X,Pintilie M et al.Dysregulated PTEN-PKB and negative receptor status in human breast cancer.Int J Cancer,2003,104(2):195

二级参考文献10

  • 1Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol, 2001,158:2097-2106.
  • 2Depowski PL, Rosenthal SI, Ross JS. Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer. Mod Pathol, 2001,14:672-676.
  • 3Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell-cycle regulators p27kip1 and cyclin E, anlone and incombination, correlate with survival in young breast cancer patients. Nat Med, 1997,3:222-225.
  • 4McIntosh GG, Anderson JJ, Milton I, et al. Determination of the prognostic value of cyclin D1 overexpression in breast cancer. Oncogene, 1995,11:885-891.
  • 5Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet, 1997,16:64-67.
  • 6Feeihoff D et al. Exclusion of a major role for the PTEN tunour-suppressor gene in breast cancinomas. Br J Cancer 1999,79:754-758.
  • 7Perren A, Weng LP, Boag AH, et al. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinnomas of the breast. Am J Pathol, 1999,155:1253-1260.
  • 8Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science,1998,280:1614-1617.
  • 9Weng LP, Smith WM, Dahia PL, et al. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Cancer Res, 1999,59:5808-5814.
  • 10Lu Y, Lin YZ, LaPushin R, et al. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Oncogene,1999,18:7034-7045.

共引文献26

同被引文献103

引证文献7

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部